SB 6602 - DIGEST

Provides that, in a products liability action alleging that an injury was caused by a failure to provide adequate warnings or information with regard to a pharmaceutical product, the defendant or defendants shall not be liable with respect to such allegations if the warnings or information that accompanied the product in its distribution were those required by the United States food and drug administration for a product approved pursuant to the federal food, drug, and cosmetic act (21 U.S.C. Sec. 321, et seq.) or section 351 of the public health service act (42 U.S.C. Sec. 262), or the warnings provided were those set forth in monographs developed by the United States food and drug administration for pharmaceutical products that may be distributed without an approved new drug application.